Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Krishna Vaddi Insider Profile
4 Followers
Krishna Vaddi, CEO, Director at Prelude Therapeutics, holds 2.72M shares in Prelude Therapeutics (Ticker: PRLD). Most recently, Krishna Vaddi Bought $1,900 shares of Prelude Therapeutics on May 26, 2023 for an estimated value of 9.79K.
Krishna Vaddi Prelude Therapeutics (PRLD)CEO, Director
Prelude Therapeutics (PRLD)
CEO, Director
Ranked #74,047 out of 98,624 Corporate Insiders
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-22.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO, Director
Roles that Krishna Vaddi holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Dec 21, 2022 - Dec 21, 2023
Return:-17.10%
The most profitable trade made by Krishna Vaddi
Krishna Vaddi's Trading History
List of latest transactions for each holding click on a transaction to see Krishna Vaddi's performance on stock
You May Also Like
Krishna Vaddi insider profile FAQ
What is the percentage of profitable transactions made by Krishna Vaddi?
The percentage of profitable transactions made by Krishna Vaddi is 0%.
What is the average return per transaction made by Krishna Vaddi?
The average return per transaction made by Krishna Vaddi is -22.00%.
What stocks does Krishna Vaddi hold?
Krishna Vaddi holds: PRLD stocks.
What was Krishna Vaddi’s latest transaction?
Krishna Vaddi latest transaction was an Informative Buy of $9.79K.
What was Krishna Vaddi's most profitable transaction?
Krishna Vaddi’s most profitable transaction was an Informative Buy of PRLD stock on December 21, 2022. The return on the trade was -17.10%.
What is Krishna Vaddi's role in Prelude Therapeutics?
Krishna Vaddi's role in Prelude Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.